weight loss semaglutide vs tirzepatide Semaglutide: Which One Should You Choose? Semaglutide vs. Tirzepatide: Which Weight

Major weight loss, pain relief seen with Eli Lilly's next-gen drug in late-stage trial Retatrutide reduced knee pain by up to 75.8% in late-stage trial A new weight-loss drug that Eli Lilly is testing is helping patients in a late-stage trial lose an average of 28.7% of their body weight and offered "substantial" relief from osteoarthritis pain

Semaglutide only targets one hormone: GLP-1

Simultaneously, long-acting approaches such as Amylyx Pharmaceuticals imapextide (MBX 1416) are gaining attention due to their once-weekly dosing potential, which may improve patient adherence, reduce treatment burden, and provide more sustained protection against recurrent hypoglycemic episodes

Disclaimer: This article is for educational purposes only and should not be taken as medical advice

You can also incorporate it into your daily routine on an empty stomach or with a meal to consistently harness its fat-to-energy conversion benefits